AnaCardio
AnaCardio develops oral medicines intended to improve heart muscle contraction in people with heart failure.
€62.5MSeries B
ParticipantI
Industrifonden
industrifonden.com ↗Activity from announced rounds
Activity in this selectionOct 16, 2026 · Jul 19, 2026
Industrifonden is an evergreen venture investor supporting technology and life-science companies in Sweden and the wider Nordic region.
Investment focus
Its long-term capital structure allows investment beyond a fixed fund term. The stated areas include human health, enterprise software and AI, and technologies emerging from science and engineering, with support for businesses scaling internationally.
Activity recorded by RoundOS
RoundOS examples include AnaCardio’s heart-failure therapeutics, Pixelgen’s molecular analysis technology, Trialbee’s clinical-trial recruitment and Soundtrap’s collaborative audio software. They illustrate distinct life-science and software activity in this database, rather than the investor’s full portfolio.
Sources
- Rounds participated in
- 4
- Confirmed lead rounds
- 1 1 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $98.2M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionEnginZyme
EnginZyme develops cell-free biomanufacturing technology that uses immobilized enzymes to make chemicals and ingredients through scalable industrial processes.
SEK 75MEquity round
ParticipantSoundtrap
Soundtrap is a cloud-based digital audio workstation for creating music and podcasts in a browser. Creators record, arrange and edit audio in shared projects, invite collaborators to work in real time and draw on built-in loops and sounds; the same platform also supports classroom music and podcast projects for educators and students.
SEK 40MFunding round
LeadPixelgen Technologies
High-throughput platform mapping molecular cell architecture at nanoscale resolution
$15.5MSeries B
Role not disclosed